Friday Feb 7
CytRx's Aldoxorubicin's Potential Is Underestimated, Creating A Buying Opportunity
Investing in early stage biotech companies calls for a lot of understanding in regard to the processes related to drug testing and approval, and so is a unique challenge.
Kite Pharma, Inc. Appoints As Chief Financial Officer
A veteran financial and operational executive, Ms. Butitta brings over 20 years' experience in leadership roles in the biotech and technology industries.